Healthy Donors
1
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Abbottcollection of follow-up sample based on PRISM HIV O Plus result
CheckMabNovel Targets for the Development of Monoclonal Antibodies for Immunotherapy)
Clinical Trials (2)
Total enrollment: 24,711 patients across 2 trials
Evaluation of a Human Immunodeficiency Virus (HIV) Blood Screening Assay
Start: Aug 2007Est. completion: Aug 200824,111 patients
Phase 3Completed
Novel Targets for the Development of Monoclonal Antibodies for Immunotherapy)
Start: Apr 2023Est. completion: Jun 2026600 patients
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs, potential near-term approvals
1 actively recruiting trials targeting 24,711 patients
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.